Fewer than half of young adults with severely high low-density lipoprotein (LDL-C), or “bad” cholesterol, levels start taking a statin within five years of first high LDL-C measurement, according to a study published in JACC, the flagship journal of the American College of Cardiology, and presented at the American Heart Association’s 2025 Scientific Sessions. The 2018 ACC/AHA Cholesterol Guideline recommends a statin in patients with LDL-C over 190 mg/dL and these findings highlight significant care gaps in lipid management among adults aged 18 to 39, particularly those at high risk for premature atherosclerotic cardiovascular disease (ASCVD).

A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease: exercise.

That is the conclusion of a Rutgers-led study published in The Journal of Clinical Endocrinology & Metabolism, which found that metformin blunts critical improvements in blood vessel function, fitness and blood sugar control that normally come from working out.

Most pharmacies in British Columbia can provide the abortion pill mifepristone within days, but uneven access still leaves some women facing barriers to this time-sensitive medication, according to new research. 

About The Study: The results of this study of pharmacies in British Columbia, Canada, suggest that when medication abortion is available as a routine health service and mifepristone is regulated as a routine prescription, pharmacists play a key role in providing geographically distributed access to medication abortion. These findings may inform policy and initiatives to enhance pharmacist referral networks and improve mifepristone access, as well as service planning for international jurisdictions considering a similar medication abortion framework.